Gogo Ai Network Inc. (GOGAF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Gogo Ai Network Inc. (GOGAF) trades at $0.1271. Gogo Ai Network Inc. , based in Vancouver, Canada, specializes in funding companies within the healthcare technology sector. The company, formerly MedBright AI Investments Inc. Market cap: $14.3M, Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Jun 15, 2026Analyst Coverage for GOGAF: GOGAF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GOGAF against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
Not enough scored data yet to form a council read on GOGAF.
How is this calculated? →Gogo Ai Network Inc. (GOGAF) Financial Services Profile
Gogo Ai Network Inc., a Vancouver-based entity, focuses on funding companies within the healthcare technology sector. Formerly MedBright AI Investments Inc., it rebranded in January 2026. Operating in financial services, its market position involves capital deployment into a specialized, high-growth niche, while navigating the unique dynamics of the OTC Other market.
What Is the Investment Thesis for GOGAF?
Gogo Ai Network Inc. presents an investment profile centered on its specialized focus within the high-growth healthcare technology sector, operating as an asset management firm. With a market capitalization of $14.3M and a P/E ratio of 3.76, the company exhibits a lean valuation relative to its substantial profit margin of 296.8%. This high profit margin, however, contrasts with a low gross margin of 9.8%, suggesting that profitability may be driven by non-operating income or specific investment gains rather than robust core operational efficiency. The company's Beta of 1.08 indicates a volatility slightly higher than the broader market. Key value drivers include its niche specialization in healthcare technology, a sector experiencing significant innovation and demand. Potential growth catalysts involve successful identification and funding of disruptive health tech ventures, leading to portfolio appreciation and lucrative exits. However, significant risks are associated with its OTC Other tier listing, which implies heightened volatility, limited regulatory oversight, and reduced public disclosure, necessitating thorough due diligence from investors. The recent rebranding in January 2026 may also signal a strategic refresh, potentially unlocking new opportunities or clarifying its market position.
Based on FMP financials and quantitative analysis
GOGAF Key Highlights
Market Capitalization of $14.3M, indicating a micro-cap company profile within the financial services sector.
- Price-to-Earnings (P/E) ratio of 3.76, suggesting a low valuation multiple relative to its reported earnings.
- Profit Margin of 296.8%, demonstrating exceptionally high profitability, potentially driven by non-recurring gains or specific investment returns.
- Gross Margin of 9.8%, which is relatively low and may indicate limited operational efficiency or high cost of revenue for its core activities.
- Beta of 1.08, signifying that the stock's price movements are slightly more volatile than the overall market.
Who Are GOGAF's Competitors?
GOGAF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AMG Affiliated Managers Group, Inc. | $356.43 | +0.29% | $9.41B | 97 |
| MAIN Main Street Capital Corporation | $58.25 | +0.14% | $5.42B | 64 |
| ALTEX Firsthand Alternative Energy Fund | $12.93 | -1.90% | $8.98M | 82 |
| BCG Binah Capital Group, Inc. | $1.40 | +0.72% | $23.5M | 78 |
| IDKFF ThreeD Capital Inc. | $0.07 | +13.85% | $6.98M | 70 |
| EEA The European Equity Fund, Inc. | $11.15 | -0.59% | $74.7M | 67 |
| HNNA Hennessy Advisors, Inc. | $9.89 | -1.30% | $78.2M | 81 |
| ETHT ProShares - Ultra Ether ETF | $12.57 | +19.94% | $92.2M | 68 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GOGAF's Key Strengths?
Niche specialization in the high-growth healthcare technology sector.
- Reported high profit margin of 296.8%, indicating strong profitability from its activities.
- Recent rebranding (January 2026) potentially signals renewed strategic focus and market positioning.
- Agile operational structure typical of a smaller, specialized investment firm.
What Are GOGAF's Weaknesses?
Small market capitalization of $14.3M, limiting capital deployment capacity and market influence.
- Low gross margin of 9.8%, suggesting potential inefficiencies in core operations or high cost of revenue.
- OTC Other tier listing, associated with heightened volatility and limited regulatory oversight.
- Lack of widely available public information on specific business model and key product lines.
What Could Drive GOGAF Stock Higher?
GOGAF catalyst: Potential for new strategic investments in high-growth healthcare technology companies, expanding its portfolio and market reach.
- Continued growth and innovation within the broader healthcare technology sector, providing a fertile ground for investment opportunities.
- Improved public disclosures or financial reporting, which could enhance investor confidence and potentially lead to an uplistment.
- Successful exits from portfolio companies (e.g., through acquisition or IPO), generating significant returns and validating its investment strategy.
- Expansion of its investment portfolio through strategic capital deployment into promising health tech ventures.
What Are the Key Risks for GOGAF?
The OTC Other tier listing presents substantial risk due to heightened volatility, limited regulatory oversight, and potential for illiquidity.
- Lack of widely available public information on its specific business model, key product lines, and portfolio companies, hindering investor analysis.
- Intense competition within the asset management and healthcare technology investment sectors, potentially impacting deal flow and returns.
- The performance of underlying healthcare technology investments is inherently risky, with high failure rates for early-stage ventures.
- A low gross margin of 9.8% suggests potential operational inefficiencies or high cost structures, which could pressure long-term profitability despite a high profit margin.
What Are the Growth Opportunities for GOGAF?
- Growth Opportunity 1: Expanding Capital Deployment in Emerging Health Tech Sub-sectors. The healthcare technology market is continuously evolving, with new sub-sectors like AI-driven diagnostics, personalized medicine platforms, and advanced telemedicine solutions emerging. Gogo Ai Network Inc. has the opportunity to strategically deploy capital into these high-growth areas, leveraging its specialized focus to identify disruptive innovations. The global digital health market, for instance, is projected to reach over $660 billion by 2028, indicating substantial room for investment and returns. By actively seeking out and funding companies at the forefront of these trends, Gogo Ai Network Inc. can enhance its portfolio value and secure a stronger market position within the next 3-5 years.
- Growth Opportunity 2: Strategic Partnerships and Co-Investment Initiatives. To amplify its investment capacity and de-risk individual ventures, Gogo Ai Network Inc. could pursue strategic partnerships with larger venture capital firms, corporate venture arms of healthcare giants, or institutional investors. Co-investment initiatives would allow the company to participate in larger funding rounds, gain access to a broader deal flow, and benefit from shared due diligence and expertise. Such collaborations could significantly expand its reach and influence within the healthcare technology ecosystem, potentially attracting more promising startups. This strategy could be implemented over the next 2-4 years, enhancing capital efficiency and portfolio diversification.
- Growth Opportunity 3: Leveraging the 'AI Network' in its Investment Thesis. While the specific application of 'AI Network' in its name is not detailed, there is an inherent opportunity for Gogo Ai Network Inc. to integrate artificial intelligence and data analytics into its investment selection and portfolio management processes. Utilizing AI for market trend analysis, predictive modeling of startup success, or even for due diligence could provide a significant competitive advantage in identifying high-potential healthcare technology companies. This could streamline decision-making, improve investment outcomes, and differentiate its offering to potential investors. Developing and implementing such capabilities could be a multi-year initiative, yielding benefits within a 3-6 year timeframe.
- Growth Opportunity 4: Enhanced Public Disclosure and Uplistment from OTC Other. Improving transparency through more comprehensive public disclosures and potentially seeking an uplistment from the OTC Other tier to a higher OTC market tier (e.g., OTCQB or OTCQX) or even a major exchange like NASDAQ, represents a significant growth opportunity. Such a move would enhance investor confidence, increase liquidity, and broaden the company's investor base beyond the limited scope of the OTC Other market. This increased visibility and regulatory compliance could attract larger institutional investors and improve valuation multiples. This strategic initiative would likely span 2-5 years, requiring sustained operational performance and robust financial reporting.
- Growth Opportunity 5: Expanding Geographic Reach for Health Tech Investments. Currently based in Vancouver, Canada, Gogo Ai Network Inc. has the opportunity to expand its investment focus beyond its immediate geographical vicinity to tap into global healthcare technology hubs. Regions like Silicon Valley, Boston, London, and Tel Aviv are epicenters of health tech innovation, offering a vast pool of potential investment targets. By establishing networks or partnerships in these key regions, the company could access a wider range of cutting-edge technologies and diversify its portfolio across different regulatory and market environments. This expansion could be a phased approach over 3-7 years, significantly enlarging its addressable market for investment opportunities.
What Threats Does GOGAF Face?
- Intense competition from larger, more established venture capital and private equity firms in health tech.
- Regulatory changes impacting OTC markets or the healthcare technology sector.
- High failure rate inherent in early-stage technology investments, impacting portfolio performance.
- Economic downturns or shifts in investor sentiment affecting capital availability and valuations in health tech.
What Are GOGAF's Competitive Advantages?
- Specialized focus on the healthcare technology sector, allowing for deep industry expertise and network development.
- Potential for proprietary deal flow derived from its niche focus and relationships within the health tech ecosystem.
- Agile investment decision-making process typical of smaller, specialized asset management firms.
- Ability to identify and support early-stage disruptive innovations within a complex and regulated industry.
What Does GOGAF Do?
Gogo Ai Network Inc., headquartered in Vancouver, Canada, operates as a specialized entity within the financial services sector, specifically focusing on asset management through its investment activities. The company's primary business revolves around funding companies within the rapidly evolving healthcare technology sector. This strategic focus positions Gogo Ai Network Inc. to capitalize on innovation and growth across various health tech sub-segments, including digital health, telemedicine, medical devices, and biotechnology. The company underwent a significant corporate rebranding, officially adopting its current name in January 2026, having previously operated as MedBright AI Investments Inc. This name change may signal a strategic pivot or a clearer articulation of its investment mandate and operational focus. While specific details regarding its proprietary investment methodologies, key product lines, or the precise nature of its portfolio companies are not widely available in public sources, its specialization suggests a venture capital or private equity-style approach to capital deployment. The company aims to identify, invest in, and nurture early to mid-stage healthcare technology firms, providing them with the necessary capital to scale operations, develop new solutions, and expand market reach. Its Canadian base provides a geographical anchor, though its investment scope could extend beyond national borders within the global healthcare technology landscape. As an asset management firm, Gogo Ai Network Inc. seeks to generate returns for its stakeholders through the successful growth and eventual exit of its portfolio companies, contributing to the broader innovation ecosystem in healthcare.
What Products and Services Does GOGAF Offer?
- Specializes in funding companies within the healthcare technology sector.
- Operates as an asset management firm, deploying capital into private companies.
- Seeks out and invests in innovative healthcare technology ventures.
- Aims to generate returns through the growth and eventual exit of its portfolio companies.
- Underwent a rebranding in January 2026, previously known as MedBright AI Investments Inc.
- Headquartered in Vancouver, Canada, with a focus on the health tech investment landscape.
How Does GOGAF Make Money?
- Invests capital into private healthcare technology companies, typically in exchange for equity stakes.
- Generates returns through the appreciation of its portfolio companies' value, leading to profits upon their acquisition or public offering.
- Potentially earns management fees or carried interest from its investment funds, though specific details are not publicly disclosed.
- Focuses on long-term value creation by supporting the development and scaling of health tech innovations.
What Industry Does GOGAF Operate In?
Gogo Ai Network Inc. operates within the Financial Services sector, specifically categorized under Asset Management. Its unique positioning stems from a dedicated focus on funding companies within the healthcare technology sector. This niche allows it to tap into a market characterized by rapid innovation, increasing demand for digital health solutions, and substantial venture capital interest. The broader asset management industry is highly competitive, with established players like Affiliated Managers Group, Inc. (AMG) and Main Street Capital Corporation (MAIN) offering diversified investment products and significant capital deployment capabilities. While Gogo Ai Network Inc.'s market capitalization of $14.3M places it as a much smaller entity compared to these peers, its specialization in healthcare technology provides a distinct competitive angle. The industry trend towards specialized funds and impact investing, particularly in sectors like healthcare, supports Gogo Ai Network Inc.'s business model. However, navigating this landscape requires deep sector expertise and robust deal-sourcing capabilities to identify promising ventures amidst intense competition for attractive investment opportunities.
Who Are GOGAF's Key Customers?
- Healthcare technology startups and growth-stage companies seeking capital for development and expansion.
- Institutional investors and accredited investors looking for specialized exposure to the healthcare technology market.
- Entrepreneurs and innovators within the health tech ecosystem seeking strategic partners and funding.
- Limited partners (LPs) in its investment vehicles, seeking returns from a focused asset management strategy.
Company Profile
Gogo Ai Network Inc. operates in the Asset Management industry within the Financial Services sector. It is headquartered in Vancouver, CA. The company is led by CEO Christopher Cherry. GOGAF has traded publicly since 2017.
Financial Health
Gogo Ai Network Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 15.41 places it in the safe zone, indicating low near-term bankruptcy risk.
Key Financial Metrics
Return on equity for Gogo Ai Network Inc. stands at 194.3%, a gauge of how efficiently it converts shareholder capital into profit. GOGAF trades at a trailing price-to-earnings ratio of 4.22, below the Financial Services sector average of ~18x. Its free cash flow yield is -1.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.09 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 23.7%, the inverse of the P/E and a quick read on earnings relative to price.
GOGAF Valuation & Market Position
With a $14.3M market cap, Gogo Ai Network Inc. sits in the micro-cap segment of the market.
GOGAF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Niche specialization in the high-growth healthcare technology sector.
- Reported high profit margin of 296.8%, indicating strong profitability from its activities.
- Recent rebranding (January 2026) potentially signals renewed strategic focus and market positioning.
- Agile operational structure typical of a smaller, specialized investment firm.
Bear Case
- Small market capitalization of $14.3M, limiting capital deployment capacity and market influence.
- Low gross margin of 9.8%, suggesting potential inefficiencies in core operations or high cost of revenue.
- OTC Other tier listing, associated with heightened volatility and limited regulatory oversight.
- Lack of widely available public information on specific business model and key product lines.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
GOGAF Latest News
No recent news available for GOGAF.
GOGAF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GOGAF.
Price Targets
Wall Street price target analysis for GOGAF.
GOGAF MoonshotScore
What does this score mean?
The MoonshotScore rates GOGAF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Christopher Cherry
Chief Executive Officer
Unknown. Specific details regarding Christopher Cherry's career history, educational background, and previous leadership roles are not publicly available in the provided source data.
Track Record: Unknown. Information regarding key achievements, strategic decisions, or company milestones directly attributable to Christopher Cherry's leadership at Gogo Ai Network Inc. is not disclosed in the provided sources.
GOGAF OTC Market Information
Gogo Ai Network Inc.'s classification on the OTC Other tier signifies that it trades on the lowest rung of the over-the-counter market. Unlike companies listed on major exchanges like NYSE or NASDAQ, which adhere to stringent listing standards for financial reporting, corporate governance, and minimum share prices, OTC Other companies face minimal disclosure requirements. This tier is typically for companies that are not required to or choose not to file reports with the SEC, or for those that are delinquent in their filings. This environment often results in less transparency and higher risk compared to higher OTC tiers or exchange-listed securities.
- OTC Tier: OTC Other
- Heightened volatility due to limited trading volume and market depth, leading to unpredictable price swings.
- Limited regulatory oversight and minimal disclosure requirements, increasing information asymmetry and potential for fraud.
- Difficulty in obtaining reliable and timely financial information, hindering comprehensive fundamental analysis.
- Potential for illiquidity, making it challenging to enter or exit positions at desired prices.
- Increased susceptibility to market manipulation due to the less regulated environment and lower trading volumes.
- Verify any available financial filings and announcements directly from the company or OTC Markets Group.
- Scrutinize the company's operational progress and capital structure for any material changes.
- Assess the credibility and track record of the management team, if information becomes available.
- Thoroughly understand the specific business model and investment strategy, seeking clarity beyond general descriptions.
- Monitor trading volumes and bid-ask spreads to gauge liquidity before making investment decisions.
- Investigate any legal or regulatory actions against the company or its management.
- Evaluate the company's corporate governance practices, even if not formally mandated.
- The company has a named CEO, Christopher Cherry, providing a point of contact for leadership.
- It has a specific stated business focus on funding companies within the healthcare technology sector.
- The company underwent a recent rebranding in January 2026, suggesting ongoing corporate activity.
- Its listing on the OTC market, while the lowest tier, still implies some level of public trading and existence.
Common Questions About GOGAF (Financial Services)
What is Gogo Ai Network Inc.'s approach to investing in the healthcare technology sector?
Gogo Ai Network Inc. specializes in deploying capital into companies within the healthcare technology sector. Its approach involves identifying and funding innovative ventures across various health tech sub-segments, such as digital health, telemedicine, and medical devices.
What are the implications of Gogo Ai Network Inc.'s OTC Other tier classification for investors?
Gogo Ai Network Inc.'s listing on the OTC Other tier carries several significant implications for investors. This tier is characterized by minimal disclosure requirements and limited regulatory oversight compared to major stock exchanges. Consequently, investors face heightened risks, including increased stock price volatility, lower liquidity, and wider bid-ask spreads, making it challenging to trade shares efficiently.
How do Gogo Ai Network Inc.'s reported financial metrics reflect its operational performance?
Gogo Ai Network Inc.'s financial metrics present a mixed picture of its operational performance. A market capitalization of $14.3M indicates a micro-cap company, while a P/E ratio of 3.76 suggests a relatively low valuation. The most striking metric is its exceptionally high profit margin of 296.8%, which typically points to significant profitability.
What are the key factors to evaluate for GOGAF?
Evaluate GOGAF on fundamentals, analyst consensus, and risk factors. Gogo Ai Network Inc. presents an investment profile centered on its specialized focus within the high-growth healthcare technology sector, operating as an asset management firm. Not financial advice.
How frequently does GOGAF data refresh on this page?
GOGAF's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven GOGAF's recent stock price performance?
Gogo Ai Network Inc. (GOGAF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Niche specialization in the high-growth healthcare technology sector. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider GOGAF overvalued or undervalued right now?
Gogo Ai Network Inc. (GOGAF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research GOGAF before investing?
Before investing in Gogo Ai Network Inc. (GOGAF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- There is a discrepancy in the source data regarding the company's sector. The 'Business Description' and 'Sector/Industry' categorize it as 'Financial Services - Asset Management' specializing in 'funding companies within the healthcare technology sector'. However, the 'Existing AI Insight' states the company 'operates within the wireless communication services sector'. This dossier prioritizes the explicit 'Business Description' and 'Sector/Industry' classification for its core business model.
- Detailed information on Gogo Ai Network Inc.'s specific business model, key product lines, and portfolio companies is not widely available in public sources, as noted in the provided data. This limits the depth of analysis possible.
- CEO background and track record details were not provided in the source data, hence marked as 'Unknown'.